Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Do Patients With Multiple Sclerosis Show Different Daily Physical Activity Patterns From Healthy Individuals?
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
The Neurophysiologist Perspective into MS Plasticity.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Identification of the Interaction Between the Human Homologue of the Arabidopsis COP9 Signalosome Subunit 7a and Olig1.
[New therapeutic options in multiple sclerosis].
Erratum to: The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Understanding How Exercise Promotes Cognitive Integrity in the Aging Brain.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
How can cognitive reserve in multiple sclerosis inform clinical care?
Palliative treatment of chronic neurologic disorders.
Cerebral adenosine A1 receptors are upregulated in rodent encephalitis.
Minocycline: Far beyond an antibiotic.
iNKT-cells and their ligands: focus on multiple sclerosis.
Hyperperfusion of Multiple Sclerosis Plaques Characterized by 3D FSE Arterial Spin Labelling.
From genetic associations to functional studies in multiple sclerosis.
Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice.
Quantified CSF antibody reactivity against myelin in multiple sclerosis.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »